Pharma News, 2019

Reeves is an associate professor in the School of Public Health and Health Sciences at the University of Massachusetts Amherst.

FOSTER CITY, Calif.

A Dr.

NEW YORK (Reuters) - Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.

Geneticists discovered a molecular trigger for a severe autism-related disorder that has enabled them to start testing a potential therapy targeting a specific protein in the brain.

The US Food and Drug Administration wants to be sure sketchy drugs don't find their way to hospitals and pharmacies, and it's mulling a technological solution to keep medicine safe.

Solid Biosciences' shares have taken a hit after early results from a study of SGT-001 microdystrophin gene transfer for the treatment of Duchenne muscular dystrophy (DMD) fell short.

Eisai and Purdue Pharma have announced six-month results from the SUNRISE 2 Phase III clinical study evaluating the efficacy and safety of lemborexant.

The US Food and Drug Administration (FDA) has approved Cablivi (caplacizumab-yhdp) as the first treatment for adult patients with a rare blood clotting disorder, acquired thrombotic th...

Vaccination represents one of the most effective means of preventing infectious disease.

According to the World Health Organization (WHO), pneumonia is responsible for 16 percent of all deaths of children under five years of age, accounting for over 920,000 child deaths in 2015.

In a new study in mouse models of Down syndrome, cannabinoid receptor type-1 has been identified as a possible target for improving cognitive disorder.